ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,376 | +26.2% | 2,753 | +22.4% | 0.00% | – |
| Q2 2023 | $44,668 | +30.5% | 2,249 | +12.5% | 0.00% | – |
| Q1 2023 | $34,224 | -9.4% | 1,999 | +4.0% | 0.00% | – |
| Q4 2022 | $37,795 | +1159.8% | 1,923 | +861.5% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 200 | -18.4% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 245 | -14.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 287 | -7.1% | 0.00% | – |
| Q4 2021 | $6,000 | -25.0% | 309 | +12.0% | 0.00% | – |
| Q3 2021 | $8,000 | -33.3% | 276 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 276 | -26.2% | 0.00% | – |
| Q1 2021 | $16,000 | +23.1% | 374 | +61.9% | 0.00% | – |
| Q4 2020 | $13,000 | +1200.0% | 231 | +645.2% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 31 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |